VTA1 antibody (AA 221-306)
Quick Overview for VTA1 antibody (AA 221-306) (ABIN7091817)
Target
See all VTA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 221-306
-
Cross-Reactivity
- Mouse, Rat
-
Predicted Reactivity
- Human,Cow,Sheep,Horse,Chicken,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human LIP5
-
Isotype
- IgG
-
-
-
-
Application Notes
- IHC-P 1:200-400
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for 12 months.
-
Expiry Date
- 12 months
-
-
- VTA1 (Vps20-Associated 1 Homolog (VTA1))
-
Alternative Name
- LIP5
-
Background
-
Synonyms: C6orf55 Chromosome 6 open reading frame 55, Dopamine responsive protein DRG 1, Dopamine-responsive gene 1 protein, DRG 1, DRG-1, DRG1, Homolog of mouse SKD1 binding protein 1, HSPC228, LIP5, LYST interacting protein 5, LYST-interacting protein 5, My012, SBP1, SKD1 binding protein 1, SKD1-binding protein 1, Vacuolar protein sorting-associated protein VTA1 homolog, Vps20 associated 1 homolog (S. cerevisiae), VTA1, VTA1_HUMAN
Background: Involved in the endosomal multivesicular bodies (MVB) pathway. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. Thought to be a cofactor of VPS4A/B, which catalyzes disassembles membrane-associated ESCRT-III assemblies. Involved in the sorting and down-regulation of EGFR. Involved in HIV-1 budding.
-
Gene ID
- 51534
-
UniProt
- Q9NP79
Target
-